Posaconazole Therapeutic Drug Monitoring in Pediatric Patients and Young Adults with Cancer
Valeria Bernardo(Cardinal Glennon Children’s Medical Center), William L. Greene(St. Jude Children's Research Hospital), Shane J. Cross(St. Jude Children's Research Hospital), Alejandro R. Molinelli(St. Jude Children's Research Hospital), James M. Hoffman(St. Jude Children's Research Hospital), Kristine R. Crews(St. Jude Children's Research Hospital), Patricia M. Flynn(St. Jude Children's Research Hospital), Jennifer L. Pauley(Cancer Research And Biostatistics), Katherine M. Knapp(St. Jude Children's Research Hospital)
Cited by 58
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Inherited <i>NUDT15</i> Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2015|443
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348